Abbott Announces New Category of Biowearables at CES 2022
Here is a brief preview of this blast: During Abbott’s Keynote at CES 2022, Abbott announced plans to develop a new category of consumer Biowearables called “Lingo” designed to help people “understand their body’s unique language” (view Keynote Speech here starting at 1:22:22). These new sensors will separately monitor glucose, ketones, lactate, and alcohol biomarkers to allow patients to make better decisions about general health, nutrition, and athletic performance (view image below). Abbott did not disclose details on the launch timing; however, the company may provide additional context during its upcoming JPM Healthcare Conference presentation on Tuesday, January 11, 2022 at 9:00 AM ET. Below, FENIX provides insights on Abbott’s Lingo platform, including thoughts on how Dexcom’s G7 may be a catalyst for it to also expand into the wellness category.